![Cris de Luca](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Cris de Luca
Directeur/Membre du Conseil chez
MediSafe, Inc.
Profil
Cris de Luca currently works at Click Therapeutics, Inc., as Director, Medisafe Project Ltd., as Director, Nucleai Ltd., as Director, Sanofi Ventures LLC, as Partner from 2020, and MediSafe, Inc., as Board member from 2021.
Mr. de Luca also formerly worked at Science 37, Inc., as Investor from 2020 to 2021.
Mr. de Luca received his graduate degree from Boston University and undergraduate degree from Suffolk University.
Postes actifs de Cris de Luca
| Sociétés | Poste | Début |
|---|---|---|
Sanofi Ventures
 Sanofi Ventures Investment ManagersFinance Sanofi Ventures nvests in companies located in the United States. The firm targets companies operating in the fields of biotech and digital health. t provides financing for seed and early stage capital requirements. It acts as lead investor and also takes a seat on board of directors. | Private Equity Investor | 01/06/2020 |
Click Therapeutics, Inc.
 Click Therapeutics, Inc. Packaged SoftwareTechnology Services Develops and commercializes software as prescription medical treatments for people with unmet medical needs | Private Equity Investor | - |
Nucleai Ltd.
 Nucleai Ltd. Packaged SoftwareTechnology Services Develops software that uses computer vision and machine learning algorithms to detect signs of cancer and gastrointestinal diseases | Private Equity Investor | - |
MediSafe, Inc.
 MediSafe, Inc. Hospital/Nursing ManagementHealth Services Develops a cloud-synced mobile medication management system | Directeur/Membre du Conseil | 01/02/2021 |
Medisafe Project Ltd.
 Medisafe Project Ltd. Hospital/Nursing ManagementHealth Services Develops a cloud-synced mobile medication management system | Private Equity Investor | - |
Anciens postes connus de Cris de Luca
| Sociétés | Poste | Fin |
|---|---|---|
Science 37, Inc.
 Science 37, Inc. BiotechnologyHealth Technology Develops mobile technology, clinical trials and patient-centric models for clinical research | Private Equity Investor | 01/12/2021 |
Formation de Cris de Luca
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
9
Relations au 1er degré
8
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 8 |
|---|---|
Click Therapeutics, Inc.
Click Therapeutics, Inc. Packaged SoftwareTechnology Services Develops and commercializes software as prescription medical treatments for people with unmet medical needs | Technology Services |
Boston University
 Boston University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Suffolk University
 Suffolk University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Sanofi Ventures
Sanofi Ventures Investment ManagersFinance Sanofi Ventures nvests in companies located in the United States. The firm targets companies operating in the fields of biotech and digital health. t provides financing for seed and early stage capital requirements. It acts as lead investor and also takes a seat on board of directors. | Finance |
MediSafe, Inc.
MediSafe, Inc. Hospital/Nursing ManagementHealth Services Develops a cloud-synced mobile medication management system | Health Services |
Medisafe Project Ltd.
Medisafe Project Ltd. Hospital/Nursing ManagementHealth Services Develops a cloud-synced mobile medication management system | Health Services |
Science 37, Inc.
Science 37, Inc. BiotechnologyHealth Technology Develops mobile technology, clinical trials and patient-centric models for clinical research | Health Technology |
Nucleai Ltd.
Nucleai Ltd. Packaged SoftwareTechnology Services Develops software that uses computer vision and machine learning algorithms to detect signs of cancer and gastrointestinal diseases | Technology Services |
Choisissez Zonebourse 
